Derivatives of venlafaxine and methods of preparing and using the same

Details for Australian Patent Application No. 2005218047 (hide)

International Classifications

Event Publications

20 October 2005 Complete Application Filed

27 October 2005 Application Open to Public Inspection

Published as AU-B-2005218047

23 November 2006 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

8 March 2007 Section 223 Application Received

Sepracor, Inc. An application to extend the time from 31 Mar 2006 to 31 Jan 2007 in which to pay the continuation fee has been filed . Address for service in Australia - Phillips Ormonde & Fitzpatrick Level 22 367 Collins Street Melbourne VIC 3000 2007

10 May 2007 Section 223 Application Allowed

Sepracor, Inc. The time in which to pay the continuation fee has been extended to 31 Jan 2007. Address for service in Australia - Phillips Ormonde & Fitzpatrick Level 22 367 Collins Street Melbourne VIC 3000 Extensions of Time, Section 223

9 July 2009 Application Accepted

Published as AU-B-2005218047

22 October 2009 Opposition Lodged

Wyeth has lodged an opposition against Sepracor, Inc.

17 June 2010 Opposition Withdrawn

The opposition by Wyeth against Sepracor, Inc has been withdrawn.

22 July 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.